Three Live CME Activities Centered on the Management of Challenging Hematologic Cancers


Friday, December 6, 2019, Orlando, Florida

Three Live CME Activities Centered on the Management of Challenging Hematologic Cancers

Friday Satellite Symposia Preceding the 61st ASH Annual Meeting

Please note that slides are for review only and not to be repurposed or published.

DATA + PERSPECTIVES: EXPLORING THE ROLE OF NOVEL AGENTS AND EMERGING STRATEGIES IN THE MANAGEMENT OF ACUTE MYELOID LEUKEMIA

Introduction:
Dr Love

MODULE 1:
Evolving Paradigms in Up-Front Treatment for Older Patients or Those Ineligible for Intensive Chemotherapy — Dr Pollyea

MODULE 2:
Assessment, Incidence and Clinical Significance of FLT3 Mutations in AML — Dr Stone

MODULE 3:
Long-Term Treatment for Patients with AML with IDH Mutations — Dr Levis

MODULE 4:
Other Novel Agents and Promising Strategies Under Evaluation for Patients with AML — Prof Wei

Live Poll Results
Download

ADDRESSING CURRENT QUESTIONS AND CONTROVERSIES IN THE MANAGEMENT OF LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA (PART 1 OF A 2-PART SERIES)

Introduction:
Dr Love

MODULE 1:
Evolving Therapeutic Algorithms for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia (CLL) — Dr Kahl

MODULE 2:
Management of Relapsed/Refractory (R/R) CLL and Novel Investigational Approaches — Prof Gribben

MODULE 3:
Contemporary Management of Newly Diagnosed and R/R Follicular Lymphoma (FL) — Dr Cheson

MODULE 4:
Protocol and Off-Protocol Care for Patients with Mantle Cell Lymphoma (MCL) — Dr Abramson

MODULE 5:
Recent Breakthroughs and Other Promising Approaches in the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Sehn

MODULE 6:
Integration of CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy into the Management of Lymphomas — Dr Nastoupil

Live Poll Results
Download

ADDRESSING CURRENT QUESTIONS AND CONTROVERSIES IN THE MANAGEMENT OF MULTIPLE MYELOMA, AMYLOIDOSIS AND WALDENSTRÖM MACROGLOBULINEMIA (PART 2 OF A 2-PART SERIES)

Introduction:
Dr Love

MODULE 1:
Up-Front Management of Multiple Myeloma (MM) — Dr Raje

MODULE 2:
Consolidation and Maintenance Therapy; Emerging Role of Minimal Residual Disease (MRD) — Dr Munshi

MODULE 3:
Current Management of Relapsed/Refractory (R/R) MM — Dr Mateos

MODULE 41:
Novel Strategies Under Investigation for the Treatment of MM — Dr Lonial

MODULE 5:
Therapeutic Strategies Targeting B-Cell Maturation Antigen (BCMA) in MM — Dr Berdeja

MODULE 6:
Amyloidosis (AL) and Waldenström Macroglobulinemia (WM) — Dr Orlowski

Live Poll Results
Download